• Updates from the Oncology World

    This week, several advances in the oncology world brought new hope to patients suffering from lung and pancreatic cancer. Roche’s Tecentriq gained new first-line lung cancer use while a Roswell Park Team developed a two-pronged approach to pancreatic cancer that offers promise. Oncologists received ASCO’s revised guidelines for patients and caregivers during COVID-19. The guidelines ...

    Read More
  • New COVID-19 Therapy Studies, Lung Cancer Genetic Risk, and More

    A two-combo cancer therapy has received FDA authorization for clinical researchers at a cancer center to begin a safety and effectiveness study. New data may have identified a genetic risk for lung cancer. The Trump Administration earmarked more money for states to conduct additional COVID-19 testing with an emphasis on identification and contact tracing. CMS ...

    Read More
  • Everything Old Is New Again: Testing Older Drugs in the Fight Against COVID-19

    Many pharmaceutical companies are testing and repurposing older medications to battle COVID-19. The lengthy list includes beta-blockers, drugs to combat autoimmune diseases, and stem cell therapy. The FDA issued emergency clearance for Gilead’s remdesivir to be used in hospital patients with COVID-19 experiencing acute respiratory distress. Hospitals and other healthcare providers struggle with the financial ...

    Read More
  • Testing and Medications to Fight COVID-19

    In this week’s Innovation Partners BioBlog, we sum up the week’s news about the many changes the healthcare industry is undergoing during the COVID-19 pandemic. The drive to reopen the United States economy will start in pharmacies as more pledge to increase access to COVID-19 tests. Organizations urge Congress to help unemployed people maintain or ...

    Read More
  • Cancer Drug Updates in the News

    In this week’s edition of the Innovation Partners BioBlog, we focus on updates from the world of cancer treatments. Despite many companies halting tests and clinical trials due to the COVID-19 pandemic, a few are reporting clinical trial results and the FDA has approved a treatment for advanced cholangiocarcinoma, a rare cancer of the bile ...

    Read More
  • Cancer Care in the Era of COVID-19

    This edition of the Innovation Partners BioBlog looks at cancer care in the era of COVID-19. ASCO released guidelines to help hospitals apportion scarce resources among critically ill patients, including cancer patients, during the pandemic. A new approach to prostate cancer drugs may delay drug resistance during treatment. The FDA has cleared more foreign generic ...

    Read More
  • Navigating the New Normal: The Industry Response to the COVID-19 Pandemic

    On behalf of everyone at Innovation Partners, a Happy Passover Holiday and Happy Easter to all! We’re all struggling to navigate the “new normal” during this time of uncertainty, and the healthcare industry is no exception. Drug companies have delayed or stopped many new drug launches since clinical trials have been stopped, approvals delayed, and ...

    Read More
  • How Coronavirus Is Shaping the Healthcare Industry

    As the world continues to battle the novel coronavirus (COVID-19), drug companies, healthcare providers, and others are facing unprecedented challenges, too. Bristol-Myers-Squibb joins the list of companies halting introductions and clinical trials during the pandemic. Humana and Cigna waive out-of-pocket costs for COVID-19 treatment. And cancer patients face worries about continuing or discontinuing chemotherapy treatments ...

    Read More
  • COVID-19 Changing the Healthcare Industry

    The novel coronavirus (COVID-19) has impacted every aspect of life. The biggest impact has been on the healthcare system, which finds itself adapting as quickly as possible to the pandemic threat. Lily joins a list of companies halting or stopping clinical trials temporarily until the pandemic is over. Healthcare IT finds itself shifting workers to ...

    Read More
  • The COVID-19 Epidemic: The Impact

    Innovation Partners’ BioBlog looks at the impact of the COVID-19 epidemic. The coronavirus, COVID-19, has swept the world, prompting unprecedented measures here and abroad to prevent its spread and contain the outbreak. Hospitals press Congress to end or pause Medicare sequester cuts; a new FAQ explains what services related to the coronavirus are covered by ...

    Read More